Mostrar el registro sencillo del ítem

dc.creatorKatsafadou A.I., Vasileiou N.G.C., Fthenakis G.C.en
dc.date.accessioned2023-01-31T08:33:20Z
dc.date.available2023-01-31T08:33:20Z
dc.date.issued2019
dc.identifier10.3390/pathogens8030134
dc.identifier.issn20760817
dc.identifier.urihttp://hdl.handle.net/11615/74603
dc.description.abstractThe objective of this review is to describe the usage and applicability of proteomics technologies in the study of mastitis in ewes. In ewes, proteomics technologies have been employed for furthering knowledge in mastitis caused by various agents (Staphylococcus aureus, Staphylococcus chromogenes, Mannheimia haemolytica, Streptococcus uberis, Mycoplasma agalactiae). Studies have focused on improving knowledge regarding pathogenesis of the infections and identifying biomarkers for its diagnosis. Findings have revealed that ewes with mastitis mount a defence response, controlled by many proteins and over various mechanisms and pathways, which are interdependent at various points. Many proteins can participate in this process. Moreover, as the result of proteomics studies, cathelicidins and serum amyloid A have been identified as proteins that can be used as biomarkers for improved diagnosis of the disease. In the long term, proteomics will contribute to improvements in the elucidation of the pathogenesis of mastitis. Further in-depth investigations into the various proteomes and application of new methodological strategies in experimental and clinical studies will provide information about mastitis processes, which will be of benefit in controlling the disease. Improvement of diagnostic techniques, establishment of prognostic tools and development of vaccines are key areas for targeted research. © 2019 by the authors. Licensee MDPI, Basel, Switzerland.en
dc.language.isoenen
dc.sourcePathogensen
dc.source.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85075446912&doi=10.3390%2fpathogens8030134&partnerID=40&md5=9dc94ded4539fb798ce1a92cd5b9f129
dc.subjectcathelicidinen
dc.subjectserum amyloid Aen
dc.subjectdisease controlen
dc.subjectdrug designen
dc.subjectelectrospray mass spectrometryen
dc.subjecteween
dc.subjectimmunoblottingen
dc.subjection trap mass spectrometryen
dc.subjectliquid chromatography-mass spectrometryen
dc.subjectMannheimia haemolyticaen
dc.subjectmastitisen
dc.subjectmatrix assisted laser desorption ionization time of flight mass spectrometryen
dc.subjectmilk productionen
dc.subjectMycoplasma agalactiaeen
dc.subjectnonhumanen
dc.subjectpathogenesisen
dc.subjectpolyacrylamide gel electrophoresisen
dc.subjectprognosisen
dc.subjectprotein analysisen
dc.subjectproteomicsen
dc.subjectReviewen
dc.subjectStaphylococcusen
dc.subjectStaphylococcus aureusen
dc.subjectStaphylococcus chromogenesen
dc.subjectStreptococcus uberisen
dc.subjecttwo dimensional polyacrylamide gel electrophoresisen
dc.subjectMDPI AGen
dc.titleUse of proteomics in the study of mastitis in ewesen
dc.typeotheren


Ficheros en el ítem

FicherosTamañoFormatoVer

No hay ficheros asociados a este ítem.

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem